ARTICLE SUMMARY:
The carotid stenting industry has faced enormous challenges over the years, but Silk Road Medical believes it has a solution that could finally move this market forward. Its strategy: giving surgeons (who still control the vast majority of the carotid intervention caseload) their own innovative pathway into the carotid stenting arena.
Not that long ago, carotid stenting looked like the next major clinical procedure that would move from surgeons to interventionalists, following in the footsteps of coronary and peripheral stenting.
